BMC kit reagents were reconstituted as follows. Reagent 1: Bottles 1 (3 mL of dipotassium hydrogen phosphate/ citrate buffer, pH 5.0) and 2 (0.5 mL of oxalate decarboxylase suspension, 8 U) were mixed in a volume ratio of 2:1. The volume required per test was 30 pL. Bottle 1 buffer was used for the blank. Reagent 2: The contents of Bottle 4(420 mg of lyophilized NAD, Li salt) were dissolved with buffer from Bottle 3 (45 mL of dipotassium hydrogen phosphate buffer, 0.1 molJL, pH 9.5). The volume required per test was 250 p.L (500 L for sample and blank). Reagent 3: The contents of Bottle 5 (200 mg of formate dehydrogenase lyophiuizate, 80 U) were dissolved in 2.4 niL of de-ionized water. The volume required per test was 20 L (40 ML for test and blank). These reagents were all stable for two days at 4#{176}C.
Aqueous EDTA was prepared at a concentration of 0.3 moIJL (100 g/L).
Standards:
Oxalate stock standard (5000 pmolIL) was prepared in de-ionized water and adjusted to pH <2 with concentrated HC1. Working standards with concentrations of 500 and 750 pmol/L were prepared.
Control: Urine was pooled, adjusted to pH 2 with HC1, and stored at 4#{176}C.
Specimens
We analyzed 24-h urine specimens that had been collected with 6 mol/L HC1 as preservative, or that were acidified to pH <2 with concentrated HC1 and allowed to sit at room temperature overnight before analysis, to dissolve precipitated oxalate.
Procedures
Sample preparation. Filter samples through no.42 filter paper (Whatman Lab. Products, Clifton, NJ). Pipette 4 mL of sample, control, and standard into small culture tubes. 
Analytical variables.
We assessed the effect of adjusting the pH of the specimens before analysis by adjusting the pH of aliquots of three urines to 4.85-5.0, 6, and 9.
Within-run precision was determined by performing replicate analyses on two urine samples. Between-run precision was determined by assaying the same pooled urine control in 47 assays. Linearity was assessed by assaying dilutions of a 1000 mol/L standard.
Analytical-recovery studies were performed by adding 50 pL of EDTA solution (final concentration 0.5 g/L) to 10-mL aliquots of filtered urine, adjusting the pH to 4.85-5.0, adding various volumes of the oxalic acid stock standard to the aliquots, and analyzing for oxalate.
We assayed 125 urine specimens by both the enzymatic procedure and the manual chemical method of Hodgkinson and Williams (7) .
To assess the effect of ascorbic acid we used four urine specimens from two individuals who ingested 5 g of ascorbic acid per day. Aliquots of these urines were adjusted to pH 5.0, ascorbate oxidase was added, and the aliquots were incubated at room temperature.
The conversion of ascorbate to dehydroascorbate was evaluated by measuring the latter colorimetrically (9). Oxalate was also added to aliquota of these urines for analytical-recovery studies, and was measured before and after treatment with ascorbate oxidase. The reference interval was determined by use of 24-h urine collections from 35 hospital-worker volunteers.
Results and Discussion

Within-run
CVs were 1.3% (n = 10) and 1.6% (n = 9) for concentrations of oxalate of 217 and 418 .tmol/L, respectively. The between-run CV was 3.4% (265 mol/L, n = 47); between-run CVs were 10-12% with the manual chemical method.
Results by our procedure were linearly related to oxalate concentrations up to 1000 pmol/L. No patients' specimens required dilution. Recovery (Table 2) Because some chemical (10) and enzymatic (3) methods for oxalate determination are interfered with by ascorbate, we checked the effect of ascorbate, measuring the conversion of ascorbate by ascorbate oxidase to dehydroascorbate. Measurement of oxalate on the aliquota before and after treatment with ascorbate oxidase demonstrated no substantial differences (results averaged within 6% of one another, and analytical recovery averaged 101%).
The reference interval determined on 24-h urine specimens from 35 hospital volunteers was 150 to 450 zmol per day.
Our initial problems in automation of this procedure concerned the inability of the Fara analyzer to pipette four reagents; therefore, we reformulated the reagents into a three-reagent chemistry. The pH adjustment of urine specimens to 4.85-5.0 must be precise. Because the second reaction has a pH optimum of about 7.5, the second buffer must have sufficient buffering capacity to change the pH of the reaction to pH 7.5, and the first reaction cannot be highly buffered. The pH of the first reaction mixture was 5.00. The pH of the final reaction mixture was 7.10 for the test, 7.21 for the blank.
Compared with samples that were adjusted to pH 4.85-5.0, samples adjusted to pH 6.1-6.8 were usually turbid and the results were high by 2% to 37%. Samples adjusted to pH 9.5-9.9 gave results that were high by 2% to 163%. Samples adjusted to a high pH, then adjusted back to pH 5.0, remained turbid and gave results that were high by 1% to 95%. In summRry, the increases varied greatly. In our procedure, if the pH exceeds 5.0 the aliquot is discarded and a new aliquot is taken.
Adjusting the pH to 4.85-5.0 is the most critical and time-consuming part of this procedure. The time required to perform oxalate analyses has been shortened from about 6 h for the chemical procedure to about 2 h for this automated procedure. An estimated 4% to 5% of specimens assayed by the chemical procedure had drug interferences, unusual colors being observed in various reaction steps. The enzymatic procedure has the advantage of avoiding the problem of drugs that interfere with the chemical reactions. In addition, use of a blank assay should correct for such interferences.
From 35 to 40 tests can be done with one kit. At the current kit cost of $109 Canadian, the cost per test is thus about $2.90.
We have used this procedure in our laboratory since February 1988, without problems. The normal reagent tip supplied with the Fara analyzer was replaced by the special CLIN. CHEM. 35/10, 2100-2103 (1989) dilution probe to permit greater precision of pipetting and to minimize loss of reagent on the exterior of the probe. Advantages of the procedure are greater precision, less technologist time required, and automation of a previously tedious manual procedure. Disadvantages are the requirement for precise pH adjustment and the running of sample blanks.
